The American Diabetes Association (ADA)’s 2017 Standards of Medical Care in Diabetes emphasizes psychological health, access to care, expanded and personalized treatment options, and tracking of hypoglycemia in patients with diabetes as key areas of focus.
The guidelines address screening, diagnosis, and treatment to provide better clinical outcomes for children, adults, and older patients with type 1, type 2, or gestational diabetes, and to improve the prevention and delay of type 2 diabetes.
The 2017 version also includes data from a new report on diabetes staging (“Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis”). The report focused on beta-cell dysfunction and disease stage for type 1 and type 2 diabetes, and describes approaches to clarify specific subtypes of diabetes in order to have personalized diabetes care. This was finalized by an expert team of 16 leaders who evaluated the current available evidence on various genetic and environmental routes that lead to diabetes, and how these pathways may be better characterized to offer precise treatment for patients with diabetes.
New guidelines issued by ADA in 2016 are included in the 2017 Standards of Care report. The new evidence-based clinical and research recommendations emphasize areas of assessment of psychological health and comorbidities; lifestyle management; and increased choice in treatment options, including metabolic surgery. Other key updates include guidelines on hypoglycemia and tables on estimated average monthly costs of non-insulin and insulin medications.
This comprehensive guide is available online and will be published as a supplement to the January 2017 issue of Diabetes Care.
For more information visit diabetesjournals.org.